Sublime Therapeutics

Sublime Therapeutics is a private early-stage biotechnology company in the San Francisco Bay Area developing anti-gastrin therapeutics for gastrointestinal diseases and cancer. The company is focused on a gastrin-neutralizing antibody approach intended for gastrin-driven malignancies, including pancreatic, gastric, esophageal, colorectal, and neuroendocrine tumors, as well as premalignant gastrointestinal conditions such as Barrett's esophagus. Publicly available descriptions consistently position the company as seed-stage and active, with a narrow, focused pipeline built around proprietary anti-gastrin biology. The business appears to be centered on oncology and GI disease with a precision biologics strategy rather than a broad diversified pipeline.